Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung

BACKGROUND: The variable efficacy (0–80%) of Mycobacterium bovis Bacille Calmette Guréin (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Ruchi, Dey, Bappaditya, Dhar, Neeraj, Rao, Vivek, Singh, Ramandeep, Gupta, Umesh D., Katoch, V. M., Ramanathan, V. D., Tyagi, Anil K.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586085/
https://www.ncbi.nlm.nih.gov/pubmed/19052643
http://dx.doi.org/10.1371/journal.pone.0003869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586085/
https://www.ncbi.nlm.nih.gov/pubmed/19052643
http://dx.doi.org/10.1371/journal.pone.0003869

Ejemplares similares